Posted September 20, 2019
Prasad S. Adusumilli, Leonid Cherkassky, Jonathan Villena-Vargas, Christos Colovos, Elliot Servais, Jason Plotkin, David R. Jones, Michel Sadelain. Regional Delivery of Mesothelin-targeted CAR T cell Therapy Generates Potent and Long-lasting CD4-dependent Tumor Immunity. Sci Transl Med. 2014 Nov 5;6(261):261ra151.